Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > Cagrilintide for Sale > High Purity Cagrilintide Acylated Peptide Amylin Receptor Analog for Preclinical Lab Research
High Purity Cagrilintide Acylated Peptide Amylin Receptor Analog for Preclinical Lab Research buy - large image1
High Purity Cagrilintide Acylated Peptide Amylin Receptor Analog for Preclinical Lab Research buy - image1
High Purity Cagrilintide Acylated Peptide Amylin Receptor Analog for Preclinical Lab Research buy - image2
High Purity Cagrilintide Acylated Peptide Amylin Receptor Analog for Preclinical Lab Research buy - image3
High Purity Cagrilintide Acylated Peptide Amylin Receptor Analog for Preclinical Lab Research buy - image4
High Purity Cagrilintide Acylated Peptide Amylin Receptor Analog for Preclinical Lab Research buy - image5
High Purity Cagrilintide Acylated Peptide Amylin Receptor Analog for Preclinical Lab Research buy - image6

High Purity Cagrilintide Acylated Peptide Amylin Receptor Analog for Preclinical Lab Research

TDS 62 Inquiries

Unit Price:

$87-99/UNIT EXW

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

ShenZhen

Brand:

XiWu

Packaging:

5mg*10Vials

Price valid (until):

2026-10-07

Company Type:
Trader
Location:
China
Qualification:
Main Products:

GLP-1,Retatrutide,Selank,Tirzepatide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


       Product Detail  


    Items Specifications
    Product Name
    Cagrilintide Peptide Lyophilized Powder
    Purity ≥99%
    Packing Way Foam + Carton




    Whatsapp:+85244697127

    If you are interested, please feel free to contact me at any time.


    Product Introduction

    Cagrilintide is a long‑acting acylated synthetic amylin analogue, provided as lab‑grade lyophilized white powder. Manufactured under strict quality control, it achieves HPLC purity ≥98% with favorable solubility for laboratory preparation. This research‑only peptide is widely adopted for in‑vitro cell experiments and pre‑clinical investigations focusing on metabolic and appetite‑related biological pathways. It is designed exclusively for academic research use to support peptide pharmacological mechanism exploration.

    Cagrilintide, also known as AM833, is a synthetic lipidated research peptide and structural analog of endogenous amylin. It is constructed with optimized peptide sequence and terminal lipid modification to extend molecular stability for laboratory testing. This compound is widely applied for preclinical research focusing on neuroendocrine signaling and metabolic biological pathways. Different from many metabolic research peptides acting on incretin receptors, it interacts with amylin and calcitonin related receptor complexes. Our product is offered as high-purity lyophilized powder, strictly restricted to laboratory research applications only. Each batch undergoes verification via HPLC and MS, and complete COA documents can be provided upon request.


    Mechanism of Action

    Cagrilintide acts as an agonist targeting amylin and calcitonin receptors. In research models, it participates in modulating appetite signaling pathways, slowing gastric emptying, and assisting in the regulation of whole‑body metabolic homeostasis for scientific study purposes.


    Chemical Information

    Product Name: Cagrilintide

    CAS No.: 1415456‑99‑3

    Appearance: White lyophilized powder

    Purity: ≥98%

    Grade: Lab‑grade research peptide

    Molecular Formula: C194H312N54O59S2 Molecular

    Weight: 4409.0


    Storage Condition

    Store in tightly sealed containers in cool, dry and dark conditions. Avoid moisture, high temperature and direct sunlight.


    Research Applications

    Suitable for cell biology assays, metabolic pathway analysis, appetite‑regulation mechanism research, and pre‑clinical peptide pharmacological studies. Applied in life‑science laboratories for experimental data collection and mechanism verification.

    Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 1 Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 2 Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 3 Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 4 Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 5 Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 6 Shop High Purity Pinealon 175175-23-2 Lyophilized Powder For Laboratory Study-Detailed Image 7


    Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 6 Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 7



    Packaging & Logistics

    Standard packing: 5mg, 10mg sealed vial.

    Outer package: Foam box + carton. Transportation: Normal cold chain transportation is optional. Goods will be well sealed to prevent moisture.

    Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 8 Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 9


    Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 10 Shop Retatrutide Reta Triple Agonist Peptide for Metabolic Research-Detailed Image 11


    Company Profile


    We are a high-tech enterprise oriented towards research and development, specializing in the fields of pharmaceutical raw materials, intermediates, peptide components, cosmetic raw materials, and nutritional supplement raw materials. We offer standardized large-scale production services and conduct global wholesale business. Our multiple peptide raw materials possess core physiological effects such as weight loss, muscle building, blood sugar reduction, and anti-aging, are widely applicable to the research and production demands in the pharmaceutical, beauty, and health care sectors.

    We adopt strict batch production standards and have sufficient production capacity and stable supply capabilities. All products have been professionally tested by third-party institutions and come with complete test reports and qualification certificates, ensuring stable batch quality and complete traceability. For large-scale orders, we offer competitive wholesale prices. We uphold the core values of integrity, pragmatism, innovation and development, and continuously enhance our technical strength and product quality.


    We offer comprehensive high-quality fine raw materials for the pharmaceutical, cosmetic and nutritional product industries. At the same time, we not only support standard batch purchases but also can meet the needs of pilot projects and large-scale industrial production.

    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Certificates

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    Cagrilintide;Cargliptin;Caglitide;Cagrilintide acetate;Cagrilintide peptide;Cagrilintide 5mg 10mg 15mg;Cagrilintide(Acetate form);Kagliptin

    CAS No.:

    1415456-99-3

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Other Chemical Drugs

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity. Administered once weekly.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    GLP-1,Retatrutide,Selank,Tirzepatide

    Location:

    Room 307, No. 3, Building 7, Area 4, Pingchou, Jiangdong Street, Yiwu City, Jinhua City, Zhejiang Province

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    11-50

    Year of Establishment:

    2026

  • Inquiry History
    62 Inquiries
    Country Product Purchase Quantity Date Posted
    Australia

    Cagrilintide

    1 G Aug 25, 2026
    United States

    Retatrutid3

    10 MT Aug 4, 2026
    United States

    Retatrutide

    20 MT Jul 25, 2026
    United States

    Cagrilintide

    10 MG Jul 13, 2026
    Peru

    Cagrilintide 20MG vial

    10 PCS Jul 10, 2026
    New Zealand

    Cagrilintide

    10 MG May 19, 2026
    United States

    Cagrilintide

    1 G May 18, 2026
    United States

    Cagrilintide

    20 MG May 8, 2026
    India

    Cagrilintide

    1 KG Apr 13, 2026
    United States

    Tirzepatide

    50 MT Apr 2, 2026
    India

    CAGRILINTIDE

    100 MG Mar 11, 2026
    United States

    Cagrilintide

    500 MG Feb 16, 2026
    Ghana

    carigrilintide

    10 MG Feb 9, 2026
    United States

    Cagrilintide

    20 MG Jan 13, 2026
    United States

    Cagrilintide

    1 KG Dec 15, 2025
    United States

    Cagrilintide

    1 KG Oct 11, 2025
    United States

    Cagrilintide

    25 MT Aug 13, 2025
    Germany

    Cagrilintide

    50 G Aug 3, 2025
    United States

    Cagrilintide

    10 MG Jul 3, 2025
    United States

    Cagrilintide

    1 G Jun 16, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.